Probiotec Ltd
ASX:PBP

Watchlist Manager
Probiotec Ltd Logo
Probiotec Ltd
ASX:PBP
Watchlist
Price: 2.98 AUD Market Closed
Market Cap: 242.3m AUD
Have any thoughts about
Probiotec Ltd?
Write Note

Net Margin
Probiotec Ltd

3.9%
Current
5%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.9%
=
Net Income
8.7m
/
Revenue
221.2m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
AU
Probiotec Ltd
ASX:PBP
242.3m AUD
4%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-79%
US
Eli Lilly and Co
NYSE:LLY
744.2B USD
20%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK
35%
US
Johnson & Johnson
NYSE:JNJ
373.9B USD
17%
US
Merck & Co Inc
NYSE:MRK
258.4B USD
19%
CH
Roche Holding AG
SIX:ROG
200.6B CHF
20%
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP
13%
CH
Novartis AG
SIX:NOVN
180.7B CHF
35%
US
Pfizer Inc
NYSE:PFE
146.9B USD
7%
Country AU
Market Cap 242.3m AUD
Net Margin
4%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 744.2B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.9B USD
Net Margin
17%
Country US
Market Cap 258.4B USD
Net Margin
19%
Country CH
Market Cap 200.6B CHF
Net Margin
20%
Country UK
Market Cap 161.8B GBP
Net Margin
13%
Country CH
Market Cap 180.7B CHF
Net Margin
35%
Country US
Market Cap 146.9B USD
Net Margin
7%
No Stocks Found

Probiotec Ltd
Glance View

Market Cap
242.3m AUD
Industry
Pharmaceuticals

Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-11-14. The firm owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. The Company’s products are manufactured on behalf of a range of clients, including international companies. The company also owns Multipack-LJM business, a contract packer, providing packing services for a range of pharmaceutical, consumer healthcare, cosmetics and food, and beverage companies. The firm subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Biotech Pharmaceuticals Australia Pty Ltd, Biotech Pharmaceuticals Pty Ltd, Probiotec (NSW) Pty Ltd, Australian Dairy Proteins Pty Ltd, Milton Pharmaceuticals Pty Ltd and Willie Labs Generics Pty Ltd.

PBP Intrinsic Value
3.96 AUD
Undervaluation 25%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3.9%
=
Net Income
8.7m
/
Revenue
221.2m
What is the Net Margin of Probiotec Ltd?

Based on Probiotec Ltd's most recent financial statements, the company has Net Margin of 3.9%.